Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
32
datasets available to search
ShareScore release 0.9.0
Dataset results
32 results for “antidiabetic drugs”
Data set from "Absolute Treatment Effects for the Primary Outcome and All-cause Mortality in the Cardiovascular Outcome Trials of New Antidiabetic Drugs – A Meta-Analysis of Digitalized Individual Patient Data"
<p>This data set contains the complete digitalized individual patient data that are used in the manuscript "Absolute Treatment Effects for the Primary Outcome and All-cause Mortality in the Cardiovascular Outcome Trials of New Antidiabetic Drugs – A Meta-Analysis of Digitalized Individual Patient Data", which is accepted from "Acta Diabetologica".<br> The data file is in CSV format and contains the five variables "OutcomeType" (with values "AllcauseMortality" or "PrimaryOutcome"), "Study" (denoting the respective cardiovascular outcome trial), "Treatment" (denoting the respective study treatment or placebo), "Event" (denoting if the respective has been observed (Event=1) or not (Event=0)), and "SurvivalTimeMonths" (denoting the respective time to the event or censoring in months).</p>
Comparison of NN5401 With Insulin Glargine, Both in Combination With Oral Antidiabetic Drugs, in Subjects With Type 2 Diabetes
ClinicalTrials.gov study NCT01045447. IPD Sharing: Not stated. Countries: 9. Publications: 3.
Safety and Efficacy of Oral Semaglutide Versus Dulaglutide Both in Combination With One OAD (Oral Antidiabetic Drug) in Japanese Subjects With Type 2 Diabetes
ClinicalTrials.gov study NCT03015220. IPD Sharing: YES. Countries: 1. Publications: 5.
Twelve -Month Study Observing How Insulin-naïve Patients With Type 2 Diabetes Mellitus Manage Diabetes Using Toujeo® After Oral Antidiabetic Drug Failure, the Side Effect of Toujeo®, and The Cost.
ClinicalTrials.gov study NCT03703869. IPD Sharing: YES. Countries: 18. Publications: 3.
Comparison of Subject-driven Titration of Biphasic Insulin Aspart (BIAsp) 30 Twice Daily Versus Investigator-driven Titration of BIAsp 30 Twice Daily Both in Combination With Oral Antidiabetic Drugs i
ClinicalTrials.gov study NCT01618214. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Evaluation of Insulin Glargine/Lixisenatide Fixed Ratio Combination in Patients With Type 2 Diabetes Insufficiently Controlled With Oral Antidiabetic Drug(s)
ClinicalTrials.gov study NCT03798054. IPD Sharing: YES. Countries: 4. Publications: 2.
Efficacy and Safety of Semaglutide Once-weekly Versus Exenatide ER 2.0 mg Once-weekly as add-on to 1-2 Oral Antidiabetic Drugs (OADs) in Subjects With Type 2 Diabetes
ClinicalTrials.gov study NCT01885208. IPD Sharing: Not stated. Countries: 13. Publications: 18.
A Trial Comparing Insulin Degludec/Liraglutide, Insulin Degludec, and Liraglutide in Chinese Subjects With Type 2 Diabetes Inadequately Controlled on Oral Antidiabetic Drugs (OADs)
ClinicalTrials.gov study NCT03172494. IPD Sharing: YES. Countries: 1. Publications: 1.
Quantitative 3D histochemistry reveals region-specific amyloid-β reduction by the antidiabetic drug netoglitazone
Open the record for dataset details and reuse information.
Comparison of the Patients With Diabetes Mellitus Using Either Insulin or Oral Antidiabetic Drug In Terms Of Difficult Laryngoscopy
ClinicalTrials.gov study NCT05040412. IPD Sharing: NO. Countries: 1. Publications: 3.
Anti-atherosclerotic Efficacy of Selected Antidiabetic Drugs in Patients With Coronary Artery Disease and Pre-diabetes
ClinicalTrials.gov study NCT07254572. IPD Sharing: NO. Countries: 1. Publications: 0.
Effect of Islet Autotransplantation Compared to Oral Antidiabetic Drug.
ClinicalTrials.gov study NCT01922492. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Effect of the Antidiabetic Drug Dapagliflozin on the Coronary Macrovascular and Microvascular Function in Type 2 Diabetic Patients
ClinicalTrials.gov study NCT05392959. IPD Sharing: NO. Countries: 1. Publications: 37.
Efficacy and Safety of LixiLan Versus Insulin Glargine Alone Both With Metformin in Japanese With Type 2 Diabetes Mellitus Inadequately Controlled on Basal Insulin and Oral Antidiabetic Drugs
ClinicalTrials.gov study NCT02752412. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Comparison Safety and Efficacy of Basal Insulin Lantus® (Insulin Glargine) vs NPH Insulin in Combination With Oral Antidiabetic Drugs (OADs) in Patients With Diabetes Mellitus, Type 2 (DMT2)
ClinicalTrials.gov study NCT00659477. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Comparison of Insulin Detemir or Insulin Glargine as Add on to Oral Antidiabetic Drugs in Type 2 Diabetes
ClinicalTrials.gov study NCT00283751. IPD Sharing: Not stated. Countries: 7. Publications: 1.
Effect of Novel Antidiabetic Drug Combined With Angiotensin Receptor/Neprilysin Inhibitor on Urinary Protein
ClinicalTrials.gov study NCT05922852. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Antidiabetic Drugs for Steatotic Liver Disease
ClinicalTrials.gov study NCT03646292. IPD Sharing: NO. Countries: 1. Publications: 1.
Cognitive Protective Effect of Newer Antidiabetic Drugs
ClinicalTrials.gov study NCT05347459. IPD Sharing: YES. Countries: 1. Publications: 0.
Efficacy and Safety of Efpeglenatide Versus Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Basal Insulin Alone or in Combination With Oral Antidiabetic Drug(s)
ClinicalTrials.gov study NCT03713684. IPD Sharing: NO. Countries: 3. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.